DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Pharmaceutical Contract Development and Manufacturing Market

Global Pharmaceutical Contract Development and Manufacturing Market Opportunities and Forecast 2020-2027

  • DLR2829
  • 18 September, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Pharmaceutical Contract Development and Manufacturing Market, By Services (Manufacturing (API/Bulk Drugs, Advanced Drug Delivery Formulations Packaging, Packaging, Finished Dose Formulations, Solid Formulations, Liquid Formulations, Semi-solid Formulations), Research (Oncology, Vaccines, Inflammation & Immunology, Cardiology, Neuroscience, Others), By End Users (Big Pharma, Small Pharma, Generic Pharma, Contract Research Organisations (CROs), Other) and opportunities and forecast 2020-2027

Pharmaceutical Contract Development and Manufacturing Market Overview

Increasing the number of medicine and drug in healthcare industry that demand for innovative drugs thus needful to large pharmaceutical companies try to remain competitive by conducting faster drug development with corresponding cost containment. Additionally, after the regulatory approval of the drug, these companies are left with relatively less time to deliver the drug within the market in substantial quantity. These factors are leading to greater outsourcing of producing facilities to pharmaceutical contract manufacturers.

Moreover, the influx of small and virtual start-ups with negligible manufacturing capacity is augmenting the worldwide pharmaceutical contract manufacturing market. The rising number of U.S. FDA-approved manufacturing facilities in developing countries is additionally working in favour of the expansion of the market.

The capacity utilization issues and lack of producing standardization are affecting the profitability of contract manufacturing organizations. This, in turn, is hampering the general revenue generation of the market.
 
Covid-19 Impact on Pharmaceutical Contract Development and Manufacturing Market:
 
In addition, the current Global Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Global Market. The recently published report demonstrates the elevation within the demand for the healthcare sector. The healthcare manufacturers have experienced future also as short term effect which incorporates supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption might be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and makers to the limit. In addition to the present, panic conditions have already spurred the demand for several healthcare products and services which are discussed intimately during this report. Moreover, the impact of this pandemic on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
Pharmaceutical Contract Development and Manufacturing Market Segment Overview

By Services segment, Research holds the major market share in estimated time period. Also, Globalization of clinical trials, increasing government funding for healthcare and a rise within the number of clinical sites are expected to drive the demand research segment.

By End-users, the generic pharma accounted for the most important share of this market in 2020. This share is attributed to the rising R&D efforts by these companies.
 
Market Analysis, Insights and Forecast – By Services
  • Manufacturing
    • API/Bulk Drugs
    • Advanced Drug Delivery Formulations Packaging
    • Packaging
    • Finished Dose Formulations
    • Solid Formulations
    • Liquid Formulations
    • Semi-solid Formulations
  • Research
    • Oncology
    • Vaccines
    • Inflammation & Immunology
    • Cardiology
    • Neuroscience
    • Others
Market Analysis, Insights and Forecast – By End Users
·       Big Pharma
·       Small Pharma
·       Generic Pharma
·       Contract Research Organisations (CROs)
·       Other  

Pharmaceutical Contract Development and Manufacturing Market Regional Overview

Region-wise, in terms of regions, North America  as well as Europe holds the market share within the global pharmaceutical contract manufacturing market. The expansion of those regions is supplemented by the growing geriatric population and high uptake of biologics. The increasing research activities by biotechnology companies and therefore the rising demand for generics also are contributing to the expansion of the regions. The U.S. is going to be a serious revenue contributor within the North America market. The Asia Pacific region is estimated to emerge as a lucrative market during the forecast period due to the improving healthcare infrastructure and increasing favourable government initiatives.

Pharmaceutical Contract Development and Manufacturing Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Pharmaceutical Contract Development and Manufacturing Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Pharmaceutical Contract Development and Manufacturing are highlighted below.
 
·        In January 2019, Lambda, headquartered in India, acquired the US-based Novum Pharmaceutical Research Services.
 
Pharmaceutical Contract Development and Manufacturing Market, Key Players

·       Thermo Fisher
·       Catalent, Inc.
·       Lonza Group Ltd.
·       Recipharm AB
·       AbbVie Inc.
·       Aenova Group
·       Almac Group
·       Siegfried Holding AG
·       Ingelheim International

Pharmaceutical Contract Development and Manufacturing Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Pharmaceutical Contract Development and Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product And Services
        • 5.2.1. Manufacturing
          • 5.2.1.1. API/Bulk Drugs
          • 5.2.1.2. Advanced Drug Delivery Formulations Packaging
          • 5.2.1.3. Packaging
          • 5.2.1.4. Finished Dose Formulations
          • 5.2.1.5. Solid Formulations
          • 5.2.1.6. Liquid Formulations
          • 5.2.1.7. Semi-solid Formulations
        • 5.2.2. Research
          • 5.2.2.1. Oncology
          • 5.2.2.2. Vaccines
          • 5.2.2.3. Inflammation & Immunology
          • 5.2.2.4. Cardiology
          • 5.2.2.5. Neuroscience
          • 5.2.2.6. Others
    • 5.3. Market Analysis, Insights and Forecast – By End Users
      • 5.3.1. Big Pharma
      • 5.3.2. Small Pharma
      • 5.3.3. Generic Pharma
      • 5.3.4. Contract Research Organisations (CROs)
      • 5.3.5. Other
    • 5.4. Market Analysis, Insights and Forecast – By Region
      • 5.4.1. North America
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America, Middle East, and Africa
    • 6. North America Pharmaceutical Contract Development and Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product And Services
        • 6.2.1. Manufacturing
          • 6.2.1.1. API/Bulk Drugs
          • 6.2.1.2. Advanced Drug Delivery Formulations Packaging
          • 6.2.1.3. Packaging
          • 6.2.1.4. Finished Dose Formulations
          • 6.2.1.5. Solid Formulations
          • 6.2.1.6. Liquid Formulations
          • 6.2.1.7. Semi-solid Formulations
        • 6.2.2. Research
          • 6.2.2.1. Oncology
          • 6.2.2.2. Vaccines
          • 6.2.2.3. Inflammation & Immunology
          • 6.2.2.4. Cardiology
          • 6.2.2.5. Neuroscience
          • 6.2.2.6. Others
    • 6.3. Market Analysis, Insights and Forecast – By End Users
      • 6.3.1. Big Pharma
      • 6.3.2. Small Pharma
      • 6.3.3. Generic Pharma
      • 6.3.4. Contract Research Organisations (CROs)
      • 6.3.5. Other
    • 6.4. Market Analysis, Insights and Forecast – By Country
      • 6.4.1. U.S.
      • 6.4.2. Canada
    • 7. Europe Pharmaceutical Contract Development and Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product And Services
        • 7.2.1. Manufacturing
          • 7.2.1.1. API/Bulk Drugs
          • 7.2.1.2. Advanced Drug Delivery Formulations Packaging
          • 7.2.1.3. Packaging
          • 7.2.1.4. Finished Dose Formulations
          • 7.2.1.5. Solid Formulations
          • 7.2.1.6. Liquid Formulations
          • 7.2.1.7. Semi-solid Formulations
        • 7.2.2. Research
          • 7.2.2.1. Oncology
          • 7.2.2.2. Vaccines
          • 7.2.2.3. Inflammation & Immunology
          • 7.2.2.4. Cardiology
          • 7.2.2.5. Neuroscience
          • 7.2.2.6. Others
    • 7.3. Market Analysis, Insights and Forecast – By End Users
      • 7.3.1. Big Pharma
      • 7.3.2. Small Pharma
      • 7.3.3. Generic Pharma
      • 7.3.4. Contract Research Organisations (CROs)
      • 7.3.5. Other
    • 7.4. Market Analysis, Insights and Forecast – By Country
      • 7.4.1. UK
      • 7.4.2. Germany
      • 7.4.3. France
      • 7.4.4. Italy
      • 7.4.5. Spain
      • 7.4.6. Russia
      • 7.4.7. Rest of Europe
    • 8. Asia Pacific Pharmaceutical Contract Development and Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product And Services
        • 8.2.1. Manufacturing
          • 8.2.1.1. API/Bulk Drugs
          • 8.2.1.2. Advanced Drug Delivery Formulations Packaging
          • 8.2.1.3. Packaging
          • 8.2.1.4. Finished Dose Formulations
          • 8.2.1.5. Solid Formulations
          • 8.2.1.6. Liquid Formulations
          • 8.2.1.7. Semi-solid Formulations
        • 8.2.2. Research
          • 8.2.2.1. Oncology
          • 8.2.2.2. Vaccines
          • 8.2.2.3. Inflammation & Immunology
          • 8.2.2.4. Cardiology
          • 8.2.2.5. Neuroscience
          • 8.2.2.6. Others
    • 8.3. Market Analysis, Insights and Forecast – By End Users
      • 8.3.1. Big Pharma
      • 8.3.2. Small Pharma
      • 8.3.3. Generic Pharma
      • 8.3.4. Contract Research Organisations (CROs)
      • 8.3.5. Other
    • 8.4. Market Analysis, Insights and Forecast – By Country
      • 8.4.1. China
      • 8.4.2. India
      • 8.4.3. Japan
      • 8.4.4. Australia
      • 8.4.5. South East Asia
      • 8.4.6. Rest of Asia Pacific
    • 9. Latin America, Middle East, and Africa Pharmaceutical Contract Development and Manufacturing Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product And Services
        • 9.2.1. Manufacturing
          • 9.2.1.1. API/Bulk Drugs
          • 9.2.1.2. Advanced Drug Delivery Formulations Packaging
          • 9.2.1.3. Packaging
          • 9.2.1.4. Finished Dose Formulations
          • 9.2.1.5. Solid Formulations
          • 9.2.1.6. Liquid Formulations
          • 9.2.1.7. Semi-solid Formulations
        • 9.2.2. Research
          • 9.2.2.1. Oncology
          • 9.2.2.2. Vaccines
          • 9.2.2.3. Inflammation & Immunology
          • 9.2.2.4. Cardiology
          • 9.2.2.5. Neuroscience
          • 9.2.2.6. Others
    • 9.3. Market Analysis, Insights and Forecast – By End Users
      • 9.3.1. Big Pharma
      • 9.3.2. Small Pharma
      • 9.3.3. Generic Pharma
      • 9.3.4. Contract Research Organisations (CROs)
      • 9.3.5. Other
    • 9.4. Market Analysis, Insights and Forecast – By Country
      • 9.4.1. Brazil
      • 9.4.2. Saudi Arabia
      • 9.4.3. UAE
      • 9.4.4. Rest of LAMEA
    • 10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Thermo Fisher
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Catalent, Inc.
      • 10.6. Lonza Group Ltd.
      • 10.7. Recipharm AB
      • 10.8. AbbVie Inc.
      • 10.9. Aenova Group
      • 10.10. Almac Group
      • 10.11. Siegfried Holding AG
      • 10.12. Ingelheim International

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934